Related Experiment Videos
A new congenital muscular dystrophy with mitochondrial structural abnormalities
I Nishino1, O Kobayashi, Y Goto
1Department of Ultrastructural Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Kodaira, Tokyo, Japan.
Muscle & Nerve
|January 14, 1998
Summary
This study identifies a new congenital muscular dystrophy (CMD) form in patients with intellectual disability and mitochondrial abnormalities. The disease involves muscle degeneration and enlarged mitochondria, suggesting a compensatory mechanism.
Area of Science:
- Neurology
- Genetics
- Mitochondrial Biology
Background:
- Congenital muscular dystrophy (CMD) comprises a group of inherited muscle-wasting disorders.
- Merosin-positive CMD typically presents with muscle weakness but without significant cognitive impairment.
Observation:
- Four patients from three families presented with merosin-positive CMD and severe intellectual disability.
- Clinical course was slowly progressive, with one patient developing dilated cardiomyopathy.
Findings:
- Muscle biopsies revealed dystrophic changes, including necrosis and regeneration.
- A key finding was mitochondrial depletion centrally within sarcoplasm, with peripheral megaconial mitochondria.
- In situ hybridization confirmed normal mitochondrial DNA content, suggesting a functional rather than genetic defect.
Implications:
- This represents a novel CMD subtype characterized by both neuromuscular and significant cognitive deficits.
- Megaconial mitochondrial changes may indicate a compensatory response to central mitochondrial dysfunction.
- Further research is needed to elucidate the specific molecular pathways involved in this CMD variant.